Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
79.98
-1.58 (-1.94%)
Nov 17, 2026, 3:00 PM CST

SHA:688578 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2,9072,1891,430644.17130.5218.27
Depreciation & Amortization
42.2142.2138.6139.3925.2523.46
Other Amortization
2.32.31.190.791.772.42
Loss (Gain) From Sale of Assets
-0.02-0.02--0.02-0.03-
Asset Writedown & Restructuring Costs
3.273.270.010.031.71-34.53
Loss (Gain) From Sale of Investments
-53.99-53.99-35.58-32.58-45.01-66.01
Stock-Based Compensation
25.4325.4378.26---
Provision & Write-off of Bad Debts
-0.04-0.040.16-0.711.360.5
Other Operating Activities
-64.57-42.98-45.21-36.02-29.534.72
Change in Accounts Receivable
-13.63-13.63-186.03-163.84-108.578.22
Change in Inventory
-38.29-38.2932.39-30.88-10.62-12.34
Change in Accounts Payable
217.76217.76238.62184.1467.3810.89
Change in Other Net Operating Assets
---75.0368.9173.69
Operating Cash Flow
3,0182,3231,566674.6591.6329.29
Operating Cash Flow Growth
46.53%48.31%132.12%636.28%212.82%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-80.96-186-270.22-67.88-143.83-192.25
Sale of Property, Plant & Equipment
0.22---0-
Investment in Securities
-1,943-1,943-1,6451,41681.63599.99
Other Investing Activities
-478.5592.980.08-1,255-342.02-168.56
Investing Cash Flow
-2,502-2,036-1,83592.75-404.21239.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-0.1----
Total Debt Issued
0.10.1----
Long-Term Debt Repaid
--3.01-2.38-2.58-4.87-8.97
Lease Payments
-3.01-3.01-2.38-2.58-4.87-8.97
Total Debt Repaid
-3.01-3.01-2.38-2.58-4.87-8.97
Net Debt Issued (Repaid)
-2.91-2.91-2.38-2.58-4.87-8.97
Common Dividends Paid
-540-360-292.5---
Other Financing Activities
-0.42-0.11-0.160.371.19-8
Financing Cash Flow
-543.33-363.02-295.05-2.21-3.69-16.97

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.41-1.092.844.3517.17-3.38
Net Cash Flow
-27.26-77.34-561.36769.55-299.1248.13

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,9372,1371,296606.77-52.21-162.95
Free Cash Flow Growth
56.16%64.88%113.56%---
Free Cash Flow Margin
44.58%41.19%36.42%30.06%-6.60%-30.74%
Free Cash Flow Per Share
6.534.742.881.35-0.12-0.36
Levered Free Cash Flow
1,8031,453823.28378.35-56.71-120.89
Unlevered Free Cash Flow
1,8031,453823.32378.45-56.5-120.51
Free Cash Flow After Leases
2,9342,1341,293604.19-57.08-171.92

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
1,2621,002566.32243.7212.82-15.03
Change in Working Capital
157.24157.2498.7459.585.5980.45